Metformin |
Formulary
|
Tablets 500mg, 850mg M/R tablets 500mg, 750mg, 1g Only consider using modified release metformin if the patient cannot tolerate immediate release metformin. Treatment of type 2 diabetes mellitus, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control Reduction in the risk or delay of the onset of type 2 diabetes mellitus in adult, overweight patients with implied Glucose Tolerance and/or increased HbA1C who are at high risk for developing overt type 2 diabetes mellitus and still progressing towards type 2 diabetes mellitus despite implementation of intensive lifestyle change for 3-6 months. |
LSCMMG: Metformin MHRA Drug Safety Update June 2022: Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk NICE: Type 2 diabetes: prevention in people at high risk |
|